|
Index of reports
> Cases resulting in death (20)
> Cases with Bone Marrow Failure (4)
Below is the selection of adverse event reports related to Epivir (Lamivudine) that includes cases resulting in death where reactions include bone marrow failure.
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-07-13
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-11
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-05-08
Patient: 32 year old male
Adverse reactions / side effects: Multi-Organ Failure, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Adriamycin PFS
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Endoxan
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Ganciclovir Sodium
Indication: Cytomegalovirus Enterocolitis
Start date: 2006-06-30
End date: 2006-07-19
Oncovin
Indication: Plasmablastic Lymphoma
Start date: 2006-02-01
End date: 2006-04-11
Predonine
Administration route: Oral
Indication: Plasmablastic Lymphoma
Start date: 2006-02-23
End date: 2006-03-21
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Start date: 2006-02-17
End date: 2006-07-19
Other drugs received by patient: Pentamidine Isethionate
Adverse event in 32 year old male receiving Epivir (Lamivudine)
Reported by a consumer/non-health professional from United States on 2007-04-23
Patient: 32 year old male
Adverse reactions / side effects: Renal Disorder, Diarrhoea, Dehydration, Bone Marrow Failure
Adverse event resulted in: death
Suspect drug(s):
Doxorubicin HCL
Indication: Plasmablastic Lymphoma
Efavirenz
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Endoxan
Indication: Plasmablastic Lymphoma
Epivir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
Oncovin
Indication: Plasmablastic Lymphoma
Predonine
Indication: Plasmablastic Lymphoma
Retrovir
Administration route: Oral
Indication: Acquired Immunodeficiency Syndrome
|
